Synergistic Cranial Nerve Stimulation Systems

Publication ID: 24-11857792_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Cranial Nerve Stimulation Systems,” Published Technical Disclosure No. 24-11857792_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857792_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,792.

Summary of the Inventive Concept

A novel, integrated system that combines cranial nerve stimulation with AI, IoT, blockchain, and advanced materials to treat various disorders and diseases, enhancing patient outcomes and quality of life.

Background and Problem Solved

The original patent, 'Methods for stimulation of cranial nerves', addressed the need for effective treatments for sleep disorders, breathing disorders, and other conditions. However, it had limitations in terms of personalized therapy, data security, and device integration. The new inventive concept addresses these limitations by integrating cranial nerve stimulation with distinct technologies, creating a more powerful system.

Detailed Description of the Inventive Concept

The synergistic system comprises a neuromodulation device, configured to apply electrical stimulation to a cranial nerve target, integrated with one or more of the following: an AI module for personalized therapy, an IoT network for remote monitoring and data transmission, a blockchain-based data storage system for secure patient data management, and novel biomaterials for enhanced tissue integration. The system enables real-time analysis of patient physiologic data, prediction of disease risk, and prevention of disease onset.

Novelty and Inventive Step

The new claims introduce novel combinations of cranial nerve stimulation with AI, IoT, blockchain, and advanced materials, providing a synergistic effect that enhances the original patent's functionality and value. The inventive step lies in the integration of these distinct technologies to create a more powerful, personalized, and secure system for treating various disorders and diseases.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the AI module's algorithm, the IoT network's architecture, the blockchain-based data storage system's implementation, and the novel biomaterials' composition. Additionally, the system could be adapted for use in other therapeutic areas, such as pain management, depression, or epilepsy.

Potential Commercial Applications and Market

The synergistic cranial nerve stimulation system has significant commercial potential in the healthcare industry, particularly in the areas of sleep disorders, respiratory disorders, and chronic pain management. The system's ability to provide personalized therapy, secure data management, and real-time monitoring makes it an attractive solution for patients, clinicians, and healthcare providers.

Original Patent Information

Patent NumberUS 11,857,792
TitleMethods for stimulation of cranial nerves
Assignee(s)NuXcel2, L.L.C.